Pellegrini-Giampietro D E, Gorter J A, Bennett M V, Zukin R S
Dipartimento di Farmacologia Preclinica e Clinica Mario Aiazzi Mancini, Università di Firenze, Italy.
Trends Neurosci. 1997 Oct;20(10):464-70. doi: 10.1016/s0166-2236(97)01100-4.
The abnormal influx of Ca2+ through glutamate receptor channels is thought to contribute to the loss of neurons associated with a number of brain disorders. Until recently, the NMDA receptor was the only glutamate receptor known to be Ca(2+)-permeable. It is now well established that AMPA receptors exist not only in Ca(2+)-impermeable but also in Ca(2+)-permeable forms. AMPA receptors are encoded by four genes designated gluR1 (gluR-A) through gluR4 (gluR-D). The presence of the gluR2 subunit renders heteromeric AMPA receptor assemblies Ca(2+)-impermeable. Recent studies involving animal models of transient forebrain ischemia and epilepsy show that gluR2 mRNA is downregulated in vulnerable neurons. These observations suggest that downregulation of gluR2 gene expression may serve as a 'molecular switch' leading to the formation of Ca(2+)-permeable AMPA receptors and enhanced toxicity of endogenous glutamate following a neurological insult.
通过谷氨酸受体通道的异常Ca2+内流被认为与许多脑部疾病相关的神经元丢失有关。直到最近,NMDA受体还是已知的唯一一种可通透Ca(2+)的谷氨酸受体。现在已经明确,AMPA受体不仅以Ca(2+)不可通透的形式存在,也以Ca(2+)可通透的形式存在。AMPA受体由四个基因编码,分别命名为gluR1(gluR-A)至gluR4(gluR-D)。gluR2亚基的存在使异聚体AMPA受体组装体对Ca(2+)不可通透。最近涉及短暂性前脑缺血和癫痫动物模型的研究表明,在易损神经元中gluR2 mRNA表达下调。这些观察结果表明,gluR2基因表达的下调可能作为一个“分子开关”,导致形成Ca(2+)可通透的AMPA受体,并在神经损伤后增强内源性谷氨酸的毒性。